Colorectal Cancer Trial, Recruiting NCT05424692 Sponsor: Peking Union Medical College Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05424692
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 75 years old, of any gender
  • People who have been diagnosed with colorectal cancer confirmed by a laboratory tissue or cell test
  • People with colorectal cancer who have had surgery to remove the cancer and need follow-up treatment afterward, and who have not had any treatment before the surgery
  • People who have at least one area of the tumor that can be measured and monitored
  • People who are well enough to carry out basic daily activities (this is measured using a standard scale — confirm with trial site)
  • People who are willing to take part and have signed a consent form

Who may not be able to join:

  • People whose cancer has spread to other parts of the body
  • People from whom a tumor tissue sample cannot be collected
  • People who are pregnant or currently breastfeeding
  • People who are unlikely to follow the trial's treatment plan and schedules as required
  • People who have serious heart or blood vessel complications that would prevent them from receiving follow-up treatment after surgery
  • People who have been diagnosed with another type of cancer
  • People who have a serious mental health or nervous system condition
  • People whom the trial researchers decide should not take part, for reasons specific to their situation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guole Lin, Peking Union Medical College Hospital

Phone: 13801081483

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2021
Est. completion
1 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The difference of 3-year disease-free survival rate of patients in both group

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov